Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Therapeutics II (Spring) > Antipsychotic drugs > Flashcards

Antipsychotic drugs Flashcards

(50 cards)

Start Studying
1
Q

antipsychotic targeting implications

A

-multiple receptors targeted w benefit
-unable to predict efficacy
-need to individualize tx based on response
-multiple receptors = more side effects = poor adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Autonomic antipsychotic mech and side effects

A

-muscarinic cholinoceptor blockade:
-dry mouth
-constipation
-difficulty urinating

-alpha block:
-orthostatic hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CNS antipsychotic mech and side effects

A

-dopamine block: PD, akathasia, dystonias
-supersensitivity of DA receptors: tardive dykinesia
-muscarinic block: toxic-confusional state
-histamine block: sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Typical (1st gen) antipsychotic drugs

A

-phenothiazines (chloropromazine)
-butyrophenones (haloperidol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Typical antipsychotics MOA

A

-strong D2 ANTAgonists
-affect mesolimbic system
-D1 antagonists not effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A

slide 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

typical antipsychotic clinical features

A

-effective in positive symptoms
-extrapyramidal sx side effect
-risk of tardive dykinesia after months/years of tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

typical antipsychotic structure (chlorpromazine)

A

-phenothiazine nucleus
-3 ring in row, middle one not aromatic and has N on bottom S on top

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phenothiazine drugs

A

-chlorpromazine
-promazine
-triflupromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chlorpromazine (phenothiazine)

A

-first drug that worked well
-D2 antagonist w 5HT2A activity
-multiple undesired targets (dirty drug) (antihistamine)
-no longer first line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Butyrophenone drugs

A

-haloperidol
-droperidol +/- fentanyl

-aromatic ring w F on one end and chain with 2 rings at other end

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Haloperidol

A

-butyrphenone
-more selective D2 ANTAgonist than chlorpromazine
-no longer first line bc EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Delayed onset of typical antipsychotics

A

-takes days to weeks
-delay phase: block D2 receptors, initially offset by D2 antagonism
-antagonism phase: D2 internalized (desensitization) and D2 autoreceptors respond better to DA inhibitory effect (sensitation)
-post-synaptic vs pre-synaptic?
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

slide 9 idk

A

De

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Delay phase

A

-blockade at postsynaptic D2 receptors, initially offset by
antagonist binding to D2 autoreceptors
-dopamine metabolites inc initially after start of antipsychotic tx
-graph is bell curve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

antagonism phase

A

-D2 internalized (desensitization) and D2 autoreceptors respond better to DA inhibitory effect (sensitation)
-post-synaptic vs pre-synaptic?
-as dopamine metabolite levels dec, efficacy inc
-graph is line inc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Actions of D2 antagonists in different brain regions

A

-mesolimbic : primary tx effects!!!

-basal ganglia: motor, EPS
-mesocorticol: hypofunction in scz, antagonists may cause cognitive deficits
-hypothalmus and endocrine: hyperprolactinemia
-medulla: chemoreceptor trigger zone, anti-emetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Receptor occupancy of antipsychotics

A

-determines balance between tx effects and EPS
-70-80% receptor occupancy ideal
->80% = EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Movement disorders induced by D2 antagonists

A

-EPS
-tardive dyskinesia
-neuroleptic malignant syndrome (NMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Extrapyramidal Symptoms (EPS)

A

-30-50% pt will experience
-days/weeks after initiation
-reversible
-dystonia (inc muscle tone)
-pseudoparkinsonism (muscle rigidity)
-tremor
-akathisia (restlessness)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drug therapy for EPS

Study These Flashcards
A

-anticholinergics: benztropine, trihexyphenidyl, akineton
-antihistamines: diphenhydramine
-amantadine (dopamine releasing agent)
-beta blockers: propranolol for akathisia

22
Q

Neurons involved in EPS

Study These Flashcards
A

-nigrostriatial pathway
-excitatory amplified and inhbitory diminished under D2 antagonism

23
Q

Tardive Dykinesia sx

Study These Flashcards
A

-late
-IRREVERSIBLE
-rhythmic involuntary movements of the mouth
-choreiform movements: irregular purposelessness (HD)
-athetoid (worm-like) movements
-axial hyperkinesias (to and fro movements

24
Q

Tardive Dykinesia MOA

Study These Flashcards
A

-not well understoof
-maybe adaptive response, antagonist supersensitivity of receptors to dopamine?

25
Tardive monitoring and Tx
-AIMS (abnormal involuntary movement scale) -rating scale, check q6 months -prevention: use low dose of low risk agent -reduce dose -eliminate anticholinergic drugs -VMAT2 inhibitors
26
Newer drug therapies for tardive dyskinesia
-VMAT2 inhibitors - -benazines used for huntington;s chorea
27
VMAT2
-channel protein that transports dopamine from cytosol into synaptic vesicles -inhibitors drugs used to tx tardive dyskinesia
28
Neuroleptic Malignant Syndrome (NMS)
-potentially fatal caused by D2 block -few days-2 weeks after start of tx -EPS w fever -impaired cognition -muscle rigidity
29
Neuroleptic Malignant Syndrome (NMS) tx
-overall goal is to restore dopamine balance -d/c drug -dopamine agonist -diazepam or dantrolene (muscle relaxant)
30
NMS tetrad
31
Atypical (2nd,3rd gen) antipsychotic drugs
-clozapine, olanzapine, quetiapine, asenapine -risperidone, zipraidone, lurasidone -aripiprazole -pimavanserin
32
Why do atypicals have lower risk of EPS than typicals
-presynaptic 5HT2A receptors on dopamergic neurons projecting from SN pars compacta to striatum play key role -regular binding of serotonin to pre 5HT2A reduces amount of dopamine released into synapse -in presence of typicals, post D2 receptors are blocked and serotonin reduces amount of dopamine into synapse (double whammy) -in atypicals, post D2 receptors are blocked but they also ANTAgonize presynaptic 5-HT2A = more dopamine release into synapse= maybe offset D2 antagonism = fewer EPS
33
Clozapine
-1st atypical -high efficacy for positive, some for neg -lower D2 potency = dec EPS risk
34
Clozapine side effects
-anticholinergic: sedation (H1) and orthostatic hypotension (a1) -weight gain -diabetes risk -agranulocytosis: drop in neutrophil counts = need to monitor blood weekly -QTc prolongation
35
Olanzapine
-similar to clozapine -same side effects but less severe -NO risk of agranulocytosis -risk of DRESS
36
Quetiapine
-antagonizes D2, 5-HT2A -low antimuscarinic activity (less sedation??) -antidepressant activity -prolong QTc
37
Asenapine
-lower sedation and antimuscarinic activity than quetiapine -prolongs QTc interval
38
-pine side effects
-anticholinergic: sedation (H1) and orthostatic hypotension (a1) -weight gain -diabetes risk -agranulocytosis in clozapine -DRESS in olanzapine, no QTc
39
side effect severity of atypicals
1. (most) clozapine = olanzapine 2. quetiapine, asenapine, -peridones, cariprazine, brexpiprazole 3. Ziprasidone, lurasidone, aripiprazole
40
-done drugs
-combined D2 5HT2A ANTAgonist -low EPS risk -sedation -orthostatic hypotension -low antimuscarinic activity -weight gain -diabetes -DRESS and QTc in ziprasidone
41
Risperidone
42
Ziprasidone
-DRESS and QTc prolongation
43
Lurasidone
-highly potent -less severe side effects than risperidone -DRESS and QTc?
44
Apiprazole MOA
-high affinity for D2/D3 also 5HT2A antagonist -D2 partial agonist: action varies w level of dopamine in different brain regions -partial 5HT1A agonist (good for depression
45
Apiprazole side effects
-low risk EPS -sedation -orthostatic hypotension -lower risk of wt gain, diabetes -akathisia
46
dose-response curves of aripiprazole
-when DA high, aripiprazole lowers DA response to intermediate level -when DA low, aripiprazole inc DA response to same intermediate level
47
Dopamine level-dependent activity of aripiprazole (partial agonism)
-by loweing D2 in LIMBIC system to normal range, ari reduces positive sx of SZ -by keeping D2 normal, ari dec EPS risk -by inc D2 into normal range in the CORTEX, ari reduces negative sx of SZ
48
Pimavanserin
-inverse agonist targeting 5HT2A -used to reduce PD psychosis, hallucinations, and delusions caused by dopamine tx -prolongs QTc
49
Cobenfy
-first SZ drug that doesnt target D2 -new
50
Which one of the statements below regarding atypical antipsychotics is INCORRECT: (A) Atypical antipsychotics like clozapine and olanzapine are effective in controlling positive symptoms and may improve some negative symptoms. (B) The lower risk of EPS in atypical antipsychotics is partly due to antagonism of presynaptic 5-HT 2A receptors in the striatum. (C) Quetiapine has greater anticholinergic activity than clozapine. (D) Aripiprazole modulates dopamine levels differently in the limbic system versus the striatum.
-(C) Quetiapine has greater anticholinergic activity than clozapine

Therapeutics II (Spring) (57 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions